Projects funded by the NCN
Epicutaneous (EC) application of a protein antigen as a new method to treat collagen induced arthritis (CIA) in humanized HLA-DR4-Tg mice. Clinical implications.
2011/03/B/NZ6/00801
Keywords:
skin-induced tolerance collagen induced arthritis T regulatory cells humanized HLA-DR4-Tg mice
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ6_3: Animal immunology
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Nauk o Zdrowiu
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 2 - announced on 2011-09-15
Amount awarded: 553 300 PLN
Project start date (Y-m-d): 2012-08-22
Project end date (Y-m-d): 2016-02-21
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled